- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/553 - Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
Patent holdings for IPC class C07D 239/553
Total number of patents in this class: 99
10-year publication summary
|
10
|
7
|
4
|
6
|
13
|
8
|
13
|
3
|
8
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| MyoKardia, Inc. | 105 |
7 |
| Neurocrine Biosciences, Inc. | 401 |
5 |
| Alkermes Pharma Ireland Limited | 271 |
3 |
| Industriale Chimica S.r.l. | 67 |
3 |
| Bayer Cropscience AG | 2057 |
2 |
| The General Hospital Corporation | 4710 |
2 |
| Abbvie Inc. | 1803 |
2 |
| ACEA Biosciences, Inc. | 22 |
2 |
| GE Healthcare Limited | 676 |
2 |
| Nucorion Pharmaceuticals, Inc. | 11 |
2 |
| Shanghai Ecust Biomedicine Co., Ltd. | 4 |
2 |
| Sichuan University | 560 |
2 |
| West China Hospital, Sichuan University | 196 |
2 |
| Flagship Pioneering Innovations V, Inc. | 220 |
2 |
| Jiangsu Flag Chemical Industry Co., Ltd. | 31 |
2 |
| Novagenesis Therapeutix (Suzhou) Limited | 2 |
2 |
| Shanghai Xudong Haipu Pharmaceutical Co., Ltd | 3 |
2 |
| Liangjiang Medicine Co., Ltd. | 2 |
2 |
| F. Hoffmann-La Roche AG | 7923 |
1 |
| The Regents of the University of California | 19839 |
1 |
| Other owners | 51 |